登录 查看组织和合同定价。
选择尺寸
关于此项目
线性分子式:
(CH3)2CHCH(NH2)COOCH3 · HCl
化学文摘社编号:
分子量:
167.63
NACRES:
NA.22
PubChem Substance ID:
eCl@ss:
32160406
UNSPSC Code:
12352209
EC Number:
230-454-7
MDL number:
Beilstein/REAXYS Number:
3912091
产品名称
D-缬氨酸甲酯 盐酸盐, ≥99.0% (AT)
InChI key
KUGLDBMQKZTXPW-NUBCRITNSA-N
InChI
1S/C6H13NO2.ClH/c1-4(2)5(7)6(8)9-3;/h4-5H,7H2,1-3H3;1H/t5-;/m1./s1
SMILES string
Cl.COC(=O)[C@H](N)C(C)C
assay
≥99.0% (AT)
form
crystals
optical activity
[α]20/D −15.5±2°, c = 2% in H2O
reaction suitability
reaction type: solution phase peptide synthesis
application(s)
peptide synthesis
Quality Level
存储类别
11 - Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
Eyeshields, Gloves, type N95 (US)
法规信息
新产品
此项目有
Jan Labuta et al.
Nature communications, 4, 2188-2188 (2013-07-19)
Enantiomeric excess of chiral compounds is a key parameter that determines their activity or therapeutic action. The current paradigm for rapid measurement of enantiomeric excess using NMR is based on the formation of diastereomeric complexes between the chiral analyte and
我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持